Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kezimuke Keli for acute uncomplicated lower urinary tract infection (Phase II)
CTR20223320Phase 2Active
- Sponsor
- Altay Prefecture Kazakh Medicine Hospital
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bacterial cystitis comparing Kezimuke Keli with Placebo (2 arms). Primary endpoints: Clinical cure rate, Symptom disappearance rate (urinary frequency, urgency, dysuria) at Day 12 and 4 more. Started Jan 2023; status: active.
02
Drugs
Kezimuke Keli
03
Conditions
bacterial cystitis
Beyond the preview
Go deeper on CTR20223320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223320.